Peptide Decoding
New?New to peptides?Start here →
Decoding

Pemvidutide_

Also known as ALT-801

An experimental weekly shot for weight loss and fatty liver.

Weight loss / liverGLP-1 / glucagon agonistInvestigational
Common vial size10 mg
Dose1.2 up to 2.4 mg per week (trial doses)
FrequencyWeekly
RouteUnder the skin (subcutaneous)
StatusInvestigational
CycledNot cycled in the trials

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is Pemvidutide?

Plain language first. The technical label stays, but it never stands alone.

Overview

Pemvidutide is a dual GLP-1 and glucagon agonist. In plain terms: it curbs appetite and nudges metabolism to burn more, studied for both weight loss and fatty-liver disease. It is still experimental.

What it's used for

An experimental weekly shot for weight loss and fatty-liver disease, working on two pathways.

02

How does Pemvidutide work?

What it does in the body, and where.

Pemvidutide combines GLP-1 with glucagon, and is being developed for liver disease as much as for weight.

  1. 01
    GLP-1 reduces intake, glucagon raises expenditure
    The same two-lever design as survodutide.
  2. 02
    Liver fat is the primary target
    Glucagon acts directly on the liver, which is why this pairing keeps being tested in fatty liver disease rather than only in obesity.
  3. 03
    Still investigational
    Phase 2 results only.
Receptors
HITSGLP-1glucagon2

Hits 2 receptors at once.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Weight lossInvestigational
  • Fatty liver disease (MASH)Investigational
04

How much, and do you cycle it?

The range, and whether you take breaks.

1.2 up to 2.4 mg per week (trial doses), weekly. Not cycled in the trialsTrial dose

Given continuously for the whole study period: MOMENTUM, 48 weeks. The dose is stepped up at the start, which is a ramp rather than a cycle, and no trial in this class built in a planned break.

Compare cycling across compounds →

05

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 1.2 up to 2.4 mg per week (trial doses)Trial dose

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

24 / 100 units
06

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Pemvidutide keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

07

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • No formal contraindications established
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • Vomiting that will not stop
  • Severe stomach pain that spreads to your back
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Nausea and vomiting are the main effects, mostly mild to moderate
  • Low rates of diarrhea and constipation
  • The manufacturer reports no meaningful rise in heart rate, which is a company-reported claim

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

08

Is Pemvidutide approved?

And where the numbers on this page come from.
Investigational

No. Not FDA-approved.

It is still being studied; a regulator has not cleared it for this use.

  • DoseFrom published clinical trials. Not approved by a regulator for this dose.
  • Vial sizeFrom what vendors typically list; not a recommendation.
  • Reviewed22 July 2026
10

What these words mean

Show glossary +
Titrate
Starting at a low dose and increasing it slowly over time so your body adjusts and side effects stay mild.
Subcutaneous
An injection just under the skin, into the fat layer, usually with a short, thin insulin needle.
Intramuscular (IM)
An injection into a muscle, using a longer needle.
Reconstitution
Mixing a powdered peptide with liquid (bacteriostatic water) so it can be drawn into a syringe.
Bacteriostatic water
Sterile water with a tiny amount of preservative, used to mix powdered peptides.
Concentration
How strong the mixed peptide is, in milligrams per milliliter (mg/mL). More water makes it weaker; less water makes it stronger.
Units (on the syringe)
The marks on an insulin syringe. 100 units equals 1 mL. They measure how much liquid you draw, not the dose in milligrams.
mcg and mg
Units of dose. 1 milligram (mg) equals 1,000 micrograms (mcg).
GLP-1
A natural gut hormone that lowers appetite and blood sugar. Drugs that copy it, like semaglutide, are used for weight loss.
Growth hormone secretagogue
A compound that nudges your body to release more of its own growth hormone, rather than injecting the hormone itself.
Half-life
How long a compound stays active in your body. A longer half-life means you inject less often.
Peptide vs small molecule
A peptide is a short chain of amino acids. A few items here (like MK-677 or methylene blue) are small molecules, not true peptides, but people use them the same way.
Research only
No approved dose or use in people. Sold for research and not reviewed by the FDA for safety or quality.
Investigational
Still being tested in clinical trials and not yet approved or legally sold for general use.
Banned in drug-tested sport
Prohibited by the World Anti-Doping Agency (WADA); using it can disqualify a competing athlete.

Last reviewed 22 July 2026